Kiromic BioPharma has put 31 people on furlough. The cell therapy biotech has stopped paying the employees, which make up “substantially all” of its workforce, until it raises money to ease its cash ...

J&J will now pick up almost the full tab for the phase 3 trial, and in return Nanobiotix will see the potential milestone payments that could come its way drop $105 million to $2.6 billion. Shares in ...

At a time when CRISPR companies have struggled, the Feng Zhang spinoff Arbor Biotechnologies gets a cash infusion to head to clinical trials.

Cash and cash equivalents, and time deposits of $1.1 billion, as of December 31, 2024, which Legend Biotech (LEGN) believes will provide ...

Purple Biotech (PPBT) had cash and cash equivalents and short-term deposits of $8.2 million, providing the Company a ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

The approach isn't new. App developers sometimes seek financial support from avid users and medical research institutions ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against other ...